These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4180779)
1. [Evaluation of the effectiveness of vitiligo treatment with psoralens; studies of the action mechanism]. Rudowska I Asthet Med (Berl); 1968 May; 17(5):117-24. PubMed ID: 4180779 [No Abstract] [Full Text] [Related]
2. [Studies on the mechanism of psoralens in the treatment of vitiligo]. Rudowska I Przegl Dermatol; 1965; 52(4):391-6. PubMed ID: 5832591 [No Abstract] [Full Text] [Related]
3. [Clinical trial of psoberan in vitiligo]. Mirakhmedov UM; Abidov MM Vestn Dermatol Venerol; 1976 Feb; (2):77-9. PubMed ID: 936777 [No Abstract] [Full Text] [Related]
4. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen]. Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805 [No Abstract] [Full Text] [Related]
5. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Fitzpatrick TB; Arndt KA; el-Mofty AM; Pathak MA Arch Dermatol; 1966 May; 93(5):589-600. PubMed ID: 5940924 [No Abstract] [Full Text] [Related]
6. [Current points of view on the therapy of vitiligo]. Ormea F Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771 [No Abstract] [Full Text] [Related]
7. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia]. Braĭtsev AV Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363 [No Abstract] [Full Text] [Related]
8. [4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children]. Ruíz Maldonado R; Tamayo Sánchez L Actas Dermosifiliogr; 1975; 66(9-10):513-26. PubMed ID: 1199825 [No Abstract] [Full Text] [Related]
9. Vitiligo--treatment with trimethylpsoralen. Bleehen SS Br J Dermatol; 1971 Feb; 84(2):186-8. PubMed ID: 5548475 [No Abstract] [Full Text] [Related]
10. [Prospects of the use of preparations of the psoralen group in the treatment of vitiligo patients]. Zheltakov MM; Vinokurov IN Sov Med; 1966 Aug; 29(8):110-5. PubMed ID: 5991379 [No Abstract] [Full Text] [Related]
11. [Our experience in the use of tyrosinase in vitiligo]. Kantner A Asthet Med (Berl); 1969 Dec; 18(12):235-8. PubMed ID: 4985255 [No Abstract] [Full Text] [Related]
12. Effects of psoralene on pigmentation in the hypophysectomized toad (Bufo melanostictus). Biswas NM; Deb C; Haque M; Chakraborty DP Endokrinologie; 1967; 52(3):271-5. PubMed ID: 5589138 [No Abstract] [Full Text] [Related]
13. [Histochemical changes in the skin of patients with vitiligo during treatment with Psoralen]. Abdullakhodzhaeva MS; Abidov MM Vestn Dermatol Venerol; 1968 Jan; 42(1):24-6. PubMed ID: 5741206 [No Abstract] [Full Text] [Related]
14. Some biochemical and chemotherapeutic aspects of vitiligo. Chakraborty DP Indian J Dermatol; 1966 Apr; 11(3):69-75. PubMed ID: 5945820 [No Abstract] [Full Text] [Related]
15. Treatment of vitiligo with topical trimethylpsoralen and sunlight. Africk J; Fulton J Br J Dermatol; 1971 Feb; 84(2):151-6. PubMed ID: 5548464 [No Abstract] [Full Text] [Related]